Connect Biopharma Holdings Ratios (2020-2026) | CNTB

Ratios Dec2020 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -1,051.60%-1,260.74%-26,758.33%-107,118.75%-11,449.70%
EBIT Margin (Quarter) -1,135.85%-1,378.08%-27,966.67%-110,481.25%-11,601.78%
EBITDA Margin (Quarter) -1,135.85%-1,378.08%-27,966.67%-110,481.25%-11,601.78%
Operating Margin (Quarter) -1,135.85%-1,378.08%-27,966.67%-110,481.25%-11,601.78%
Net Margin (Quarter) -1,056.28%-1,275.93%-26,872.92%-107,500.00%-11,478.11%
FCF Margin (Quarter) -1,079.08%-377.08%-26,862.50%-109,000.00%-9,469.23%
Efficiency
Assets Average (Quarter) 226.97M262.47M202.55M157.24M135.73M96.98M87.70M75.04M61.72M58.07M
Invested Capital (Quarter) 312.58M0.12M0.42M
Asset Utilization Ratio (Quarter) 0.020.010.000.00
Leverage & Solvency
Interest Coverage Ratio (Quarter) -126.33181.95-182.18-128.25-150.62-13.90-166.76-118.52-26.50
Times Interest Earned (Quarter) -126.33181.95-182.18-128.25-150.62-13.90-166.76-118.52-26.50
Valuation
Enterprise Value (Quarter) -154.39M-266.97M-194.02M-149.25M-131.57M-118.30M-110.20M-93.73M-84.01M-71.77M-54.78M-44.34M-46.03M
Return Ratios
Return on Sales (Quarter) -0.11%-0.13%-2.69%-10.75%-8.67%-1.15%
Return on Capital Employed (Quarter) -24.05%-62.80%-82.00%-120.72%-161.45%
Return on Assets (Quarter) 0.00%-0.01%-0.01%-0.01%-0.01%